JP2023535352A5 - - Google Patents
Info
- Publication number
- JP2023535352A5 JP2023535352A5 JP2023502928A JP2023502928A JP2023535352A5 JP 2023535352 A5 JP2023535352 A5 JP 2023535352A5 JP 2023502928 A JP2023502928 A JP 2023502928A JP 2023502928 A JP2023502928 A JP 2023502928A JP 2023535352 A5 JP2023535352 A5 JP 2023535352A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- composition according
- treatment
- axl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063053679P | 2020-07-19 | 2020-07-19 | |
| US63/053,679 | 2020-07-19 | ||
| PCT/US2021/042124 WO2022020218A1 (en) | 2020-07-19 | 2021-07-18 | Diagnostic methods for cancer using axl decoy receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535352A JP2023535352A (ja) | 2023-08-17 |
| JP2023535352A5 true JP2023535352A5 (https=) | 2024-09-26 |
Family
ID=79729411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502928A Pending JP2023535352A (ja) | 2020-07-19 | 2021-07-18 | Ａｘｌデコイ受容体を使用したがんの診断法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230277631A1 (https=) |
| EP (1) | EP4181961A4 (https=) |
| JP (1) | JP2023535352A (https=) |
| KR (1) | KR20230050349A (https=) |
| CN (1) | CN116194145A (https=) |
| AU (1) | AU2021312139A1 (https=) |
| CA (1) | CA3185356A1 (https=) |
| MX (1) | MX2023000810A (https=) |
| WO (1) | WO2022020218A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4693690A1 (en) | 2023-04-17 | 2026-02-11 | LG Energy Solution, Ltd. | Separator and electrochemical device including same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2749601C (en) * | 2009-01-14 | 2020-07-21 | Stephen M. Hewitt | Ratio based biomarkers and methods of use thereof |
| PT2525824T (pt) * | 2010-01-22 | 2017-07-13 | Univ Leland Stanford Junior | Inibição da sinalização de axl em terapêutica antimetastática |
| EP3703731A4 (en) * | 2017-11-04 | 2021-07-21 | Aravive Biologics, Inc. | METHOD OF TREATMENT OF METASTATIC CANCER USING AXL DECOY RECEPTORS |
| KR20210003780A (ko) * | 2018-04-05 | 2021-01-12 | 스미토모 다이니폰 파마 온콜로지, 인크. | Axl 키나제 억제제 및 그의 용도 |
-
2021
- 2021-07-18 MX MX2023000810A patent/MX2023000810A/es unknown
- 2021-07-18 WO PCT/US2021/042124 patent/WO2022020218A1/en not_active Ceased
- 2021-07-18 AU AU2021312139A patent/AU2021312139A1/en not_active Abandoned
- 2021-07-18 CN CN202180064019.0A patent/CN116194145A/zh active Pending
- 2021-07-18 KR KR1020237005673A patent/KR20230050349A/ko active Pending
- 2021-07-18 CA CA3185356A patent/CA3185356A1/en active Pending
- 2021-07-18 US US18/016,765 patent/US20230277631A1/en active Pending
- 2021-07-18 EP EP21948702.2A patent/EP4181961A4/en not_active Withdrawn
- 2021-07-18 JP JP2023502928A patent/JP2023535352A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502334A5 (https=) | ||
| EP3882265B1 (en) | Compositions and methods for treating cancer with anti-mesothelin immunotherapy | |
| CN111601823B (zh) | 用car-t或car-nk细胞在癌症治疗中靶向lilrb4 | |
| US11708408B2 (en) | Compositions and methods for treating cancer with anti-CD19 immunotherapy | |
| HRP20171653T1 (hr) | Vezna sredstva koja služe ciljano protiv b7-h1 | |
| CN115151635A (zh) | 用编码新的嵌合抗原受体的基因转导的基因修饰nk细胞系及其用途 | |
| US20230357435A1 (en) | Use of inhibitors of adam12 as adjuvants in tumor therapies | |
| Zimmerman et al. | IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells | |
| JP2023535352A5 (https=) | ||
| TWI856035B (zh) | 溶瘤病毒療法及免疫療法 | |
| TWI817350B (zh) | 與Globo系列抗原結合之嵌合抗原受體及其用途 | |
| CN120092090A (zh) | 工程化嵌合抗原受体免疫细胞及其应用 | |
| Wang et al. | Safety and clinical response to combined immunotherapy with autologous iNKT cells and PD-1+ CD8+ T cells in patients failing first-line chemotherapy in stage IV pancreatic cancer | |
| CN118891286A (zh) | Pd-l1特异性嵌合抗原受体及包含其的免疫细胞 | |
| WO2019201970A1 (en) | A mertk ligand for adoptive t cell cancer therapy | |
| JP2021512965A5 (https=) | ||
| WO2025242193A1 (zh) | 博来霉素作为免疫增强剂的用途 | |
| WO2021050936A1 (en) | Methods of treatment with cd8 t cell-mediated immune therapy | |
| JP2024516221A (ja) | 腫瘍浸潤リンパ球療法 | |
| RU2020116224A (ru) | Способы лечения метастатических видов рака с использованием рецепторов-ловушек axl | |
| JP2024534935A5 (https=) | ||
| US20260069692A1 (en) | Modified t-cells for use in the treatment of gastroesophageal cancer | |
| Zaninelli | Development of innovative CAR molecules to be transduced in Cytokine Induced Killer cells for the treatment of different neoplasia | |
| Khazamipour | Oncofetal chondroitin sulfate as a target in solid tumors | |
| Hegde et al. | Autologous HER2-specific CAR T-cells after lymphodepletion for advanced sarcoma |